“…[18][19][20][21] COSY crossp eaks were also observedu nder favorable circumstances. [18] We first presentt he 1 HNMR spectrum of [Fe IV (O)(N2Py2B)] 2+ + [16,22] (N2Py2B = N,N-bis((1-methyl-1H-benzoimidazol-2-yl)-methyl)-1,1-di(pyridin-2-yl)-methanamine); 2, Scheme 2, Figure 4a and S9, Supporting Information) to guide us in interpreting the NMR data for 1.C omplex 2 has am irror plane of symmetry that gives rise to ar elatively simple 1 HNMR spectrumw ith seven sharp signals corresponding to protons on the heterocyclic ligands; all have unit intensity except for the peak at À0.9 ppm, which represents 3h ydrogen atoms and therefore is easily assigned to the NÀCH 3 group of the N-Me-benzimidazole donor.T he peaks at 48, 9, and À19 ppm can be assigned, respectively to pyridine b-, g-, and b'-protons by analogy to peaks in the spectrum of [Fe IV (O)(N4Py)] 2+ + (Figure S11; N4Py = N,N-bis(pyridyl-2-methyl)-bis(2-pyridyl)methylamine), [18] whereas peaks at 15, 12, and 5ppm can be associated with benzimidazole C4ÀH, C5ÀH, and C6ÀHp rotons. Their assignments follow from their relaxation times T 1 andl inewidths that reflect their varying distances from the metal center (Table S6).…”